A simple method for the rapid determination of antibiotic blood levels is described. Results are readily obtainable within 4 to 6 hr. The reported procedure is based upon determination of the highest dilution of a patient's serum capable of inhibiting dextrose fermentation by a standardized inoculum of a staphylococcus strain or of an Escherichia coli strain, when colymycin or polymyxin are involved, as compared to previously determined endpoints in this regard of defined concentrations of the different antibiotics dissolved in normal human serum. Excellent correlation was observed with 36 serum specimens that contained different antimicrobial agents in varied concentrations when simultaneously assayed by the standard method and the subject procedure of this report.
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There are times when an anticipated therapeutic response fails to materialize in spite of apparently adequate antibiotic dosage. An important contributory factor to such failure may be inadequate blood and tissue concentration resulting from deficient absorption or excessive excretion. On the other hand, serious adverse side effects may follow the production of excessively high antibiotic blood levels, particularly with such antimicrobial agents as chloramphenicol, streptomycin, neomycin, and kanamycin. Early provision of accurate information with respect to the blood level status of a patient can be of critical clinical importance. With such knowledge, the physician can promptly initiate any indicated corrective dosage adjustments. The relatively complex standard method for assaying blood levels, however, requires overnight incubation so that findings in this regard cannot be made available in less than 16 hr.
The present report is concerned with a simple method for determining antibiotic blood levels through which these vital data can be provided within 4 to 6 hr, thereby permitting the physician to make any indicated dosage modification in time for the next scheduled administration of the therapeutic agent since antimicrobials are generally administered at 6-hr intervals. The procedure is based upon the determination of the highest dilution of a patient's serum after serial dilution which is still capable of inhibiting acid fermentation of dextrose by a standardized inoculum of Staphylococcus aureus or Escherichia coil as compared to previously determined endpoints elicited by prepared, set concentrations of different antibiotics dissolved in normal human serum.
MATERIALS AND METHODS
Medium. The composition of phenol red dextrose fermentation broth was as follows: Trypticase Soy Broth Powder (BBL), 27.5 g; sodium chloride, 5.0 g; dextrose, 10.0 g; phenol red in a 1.6% alcoholic solution, 1.0 ml; distilled water, 1,000 ml. The medium was autoclaved under 12 psi of pressure for 15 min.
Preparation of assay inoculum. S. aureus ATTC S 6538P was used as the assay organism for all antibiotics except polymyxin and colymycin. This staphylococcus was found resistant to the action of the latter antimicrobials so that when they were under consideration, E. coli ATJ7C S 10536, which is sensitive to both, was utilized. Both microorganisms are capable of rapid acid fermentation of the dextrose contained in the phenol red medium with resultant color change from red to yellow. The assay strain was inoculated into Trypticase Soy Broth and incubated for 6 to 8 hr at 37 C until an optical density of 0.1, as measured with a Lumetron photoelectric nephelometer (580 nm filter), was achieved. This reading was equivalent to the S1 tube of the MacFarland nephelometer (3 X 108 organism per milliliter). The culture was then centrifuged, and the supernatant fraction was decanted and replaced with an equal volume of phenol red dextrose broth. Samples of 1.2 ml of the stock phenol red dextrose broth suspension of each organism were pipetted into a series of sterile tubes and stored in a -20 C refrigerator for subsequent use. These frozen stock cultures were found to be active for at least 6 weeks so that their preparation more often than every 6 weeks is not necessary. A 1 to 10 dilution of stock suspension of S. aureus and 1 to 100 dilution of E. coll proved to be capable of completing 0.078 Preparation of composite reference graph. A series of concentrations for each antibiotic was prepared in normal human serum in half-fold decrements from 40 to 0.078 /Lg/ml. The fermentation inhibitory endpoint for each concentration was then determined as follows. A 1-ml amount of phenol red dextrose broth was pipetted into a series of 10 sterile, cotton-plugged tubes (13 by 100 mm) for each test concentration. A 1-ml amount of the antibiotic concentration under test was added and serially diluted; 1 ml of diluted seeded phenol red broth was then added to each tube. A dilution of 1 to 10 for S. aureus or 1 to 100 for E. coli was used when colymycin or polymyxin was involved. A control tube containing 0.5 ml of normal human serum, 0.5 ml of uninoculated phenol red dextrose broth, and 1.0 ml of diluted seeded phenol red dextrose broth accompanied each set of determinations. All tubes were incubated in a water bath at 37 C until a complete color change from red to yellow supervened in the control tube. The fermentation inhibitory endpoint for each test concentration of the particular antibiotic was then noted. The record in this regard of penicillin is incorporated into Table 1. After the procedure is completed for each antibiotic, results are incorporated into a composite reference graph (Fig. 1) . Inhibitory tube numbers are recorded along the abscissa, whereas prepared test concentrations in human serum are plotted logarithmically to the base of 2 along the ordinate. A number of antibiotics had similar inhibition patterns and were grouped, thus eliminating the need for separate curves for each antibiotic. All curves except that of novobiocin proved to be linear. With respect to the latter, the sharp fall off below 1.25 ug/ ml is, in all probability, a consequence of the marked serum binding property of this antibiotic that resulted in binding and inactivation of the low concentrations. Performance of test. Phenol red dextrose broth (1 mil) is pipetted into each of a series of 10 sterile, cotton-plugged tubes, labeled numerically left to right from #1 (minimum dilution) to #10 (maximum dilution). A 1-ml sample of the patient's serum is added to tube 1, serially diluted down to tube 10 after which 1 ml is aspirated and discarded from the latter tube. Diluted seeded phenol red dextrose broth (1 ml) is then added to each tube. The latter is quickly prepared by the addition of 10.8 ml of phenol red dextrose broth to a sample tube containing 1.2 ml of stock seeded broth which had been maintained in the SCHNEIERSON AND BOYLE A control tube with 0.5 ml of normal human serum, 0.5 ml of uninoculated phenol red dextrose broth, and 1.0 ml of diluted seeded broth accompanies each assay. To determine polymyxin or colymycin levels, E. coli is substituted for S. aureus as the assay organism, in which case a 1 to 100 rather than the 1 to 10 dilution is used. The entire procedure as described above can be readily performed within a few minutes.
All tubes are then incubated for 4 to 6 hr in a water bath at 37 C until a definite color change in the control tube from red to yellow is produced. The test is then read and the highest dilution of the patient's serum which affects inhibition of fermentation by the assay organism is noted.
To determine the level of antibiotic contained in the patient's serum, the fermentation inhibition endpoint (determined by tube number) is projected vertically from the abscissa of the graph to the point of intersection with the curve of the particular antibiotic under consideration (Fig. 1) . The serum concentration is then readily calculated by lateral projection to the graph ordinate. Thus, if the inhibitory endpoint of the serum of a patient receiving penicillin was observed as tube #7, the serum penicillin level would then be read off as 10.0 ,g/ml.
Assay for higher antibiotic concentrations can be performed by utilizing a greater number than the 10 tubes recommended for the procedure routinely. In this case, when the fermentation inhibitory tube is higher than tube #10, concentration can be calculated by extension along the reference curve for the particular antibiotic being tested since, as may be noted in Fig. 1 , all curves including novobiocin concentrations above 1.25 jtg/ml are linear.
RESULTS AND DISCUSSION
To test the degree of accuracy of the above described method, 36 antibiotic-containing serum specimens were simultaneously assayed by means of (i) the standard assay method and (ii) the procedure reported. Nine different antibiotics in varying concentrations were involved, including a number of specimens containing colymycin. In the latter instance, the E. coli assay strain was used in place of the usual S. aureus strain.
Results of the comparative assays are illustrated in Fig. 2 , in which serum antibiotic levels obtained by means of the standard method are plotted against those found with the method under study. The solid line represents perfect correlation between both.
As may be noted from the graph, an excellent degree of correlation was observed between both methods, thereby attesting to the accuracy of the method under investigation. Some slight variations between both are seen, but these are attributable to the dissimilar concentration increments measured between inhibitory tube endpoints in each method rather than variations in results.
